TRThomas Ritzenthaler

Thomas Ritzenthaler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Thomas Ritzenthaler has a total of 154 co-authors. Here are the top co-authors by number of shared publications:

  • Laurent Derex

    Stroke Department (P.C., E.O., L.D., L.M., N.N., T.-H.C.), East Group Hospital, Hospices Civils de Lyon, Bron, France

    12 shared publications
  • Norbert Nighoghossian

    From the Service de neurologie vasculaire, Hôpital neurologique (T.R., T.H.C., L.M., E.O., N.N.), Service de neuroradiologie interventionnelle, Hôpital neurologique (F.T.), Service de neuroradiologie, Hôpital neurologique (Y.B.), and Direction de la Recherche Clinique et de l'Innovation (P.R.), Hospices Civils de Lyon, France; and CREATIS, CNRS UMR 5220, INSERM U1044, Université Lyon 1, France (T.R., T.H.C., E.O., Y.B., N.N.).

    11 shared publications
  • Tae-Hee Cho

    From the Service de neurologie vasculaire, Hôpital neurologique (T.R., T.H.C., L.M., E.O., N.N.), Service de neuroradiologie interventionnelle, Hôpital neurologique (F.T.), Service de neuroradiologie, Hôpital neurologique (Y.B.), and Direction de la Recherche Clinique et de l'Innovation (P.R.), Hospices Civils de Lyon, France; and CREATIS, CNRS UMR 5220, INSERM U1044, Université Lyon 1, France (T.R., T.H.C., E.O., Y.B., N.N.).

    9 shared publications
  • Frédéric Dailler

    Service De Réanimation Neurologique, Hospices Civils De Lyon, Lyon, France

    8 shared publications
  • Norbert Nighoghossian

    Hospices Civils de Lyon, Department of Neurology and Stroke Center, Lyon University, France (N.N.).

    7 shared publications
  • Yves Berthezene

    Neuroradiology Department, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, 69677, Bron Cedex, France

    5 shared publications

Latest Publications

  • Évaluation de la recanalisation au cours des accidents ischémiques cérébraux : intérêt de la séquence IRM en T2* et de la spectroscopie de proche infra-rouge

    by Thomas Ritzenthaler

    A la phase aigüe des accidents ischémiques cérébraux, l'objectif thérapeutique principal est l'obtention d'une recanalisation de l'artère occluse et d'une reperfusion de la zone de pénombre ischémique. L'identification de facteurs prédictifs d'une recanalisation et le développement de nouveaux outils de surveillance est d'un intérêt majeur lors de la mise en oeuvre de ces thérapeutiques. Dans la première partie de notre travail, nous avons étudié la valeur pronostique de la visibilité initiale du thrombus sur les séquences IRM en T2* et son évolution lors d'acquisitions séquentielles chez les patients traités par thrombolyse intraveineuse. Nous avons confirmé la valeur péjorative cette visibilité initiale, et souligné les discordances entre les données de l'angioIRM et de la séquence T2* lors de l'analyse séquentielle. Dans la seconde partie du travail, nous avons évalué l'intérêt de la spectroscopie de proche infrarouge comme méthode permettant d'évaluer le bénéfice de la recanalisation chez les patients traités par thrombectomie mécanique. Cette technologie semble intéressante, mais présente cependant des limites discutées dans ce travail

  • Effect of fludrocortisone in the management of hyponatremia after aneurysmal subarachnoid hemorrhage

    by Matthieu Sadoul, Baptiste Balança, Frédéric Dailler, Thomas Ritzenthaler

    Aneurysmal subarachnoid hemorrhage (aSAH) is associated with significant morbidity, particularly related to delayed cerebral ischemia (DCI). Hyponatremia, defined as a serum sodium level < 135 mmol/l, is a common complication of aSAH and is associated with the development of DCI. Fludrocortisone is used to decrease natriuresis and improve hyponatremia, but has failed to demonstrate a reduction in the frequency of cerebral vasospasm or DCI. Using the ProReSHA database, we retrospectively analyzed the impact of fludrocortisone on the development of DCI in patients hospitalized in neurocritical care unit after aSAH and presenting hyponatremia. Two hundred sixteen patients were included, 88 in the fludrocortisone group and 128 in the control group. DCI occurred in 35 (39.8%) patients in the fludrocortisone group and 34 (26.6%) in the control group (p = 0.058). Hyponatremia was significantly deeper in the fludrocortisone group than in the control group (median [interquartile range]: 130 [128–131] vs. 132 [131–133] mmol/l; p < 0.001), and lasted longer (6.0 [4.0–8.3] vs. 3.0 [2.0–5.0] days; p < 0.001). An ancillary analysis stratified according to the etiology of hyponatremia (cerebral salt wasting syndrome or syndrome of inappropriate secretion of antidiuretic hormone) also found no significant difference regarding DCI occurrence (33.3% vs. 44.6%; p = 0.238) but a significantly lower natriuresis in the cerebral salt wasting syndrome group (225 [187–308] vs. 293 [253–359] mmol/d; p = 0.01). Fludrocortisone did not prevent the development of DCI in patients admitted to a neurocritical care unit for an aneurysmal subarachnoid hemorrhage and presenting with hyponatremia. Effect of fludrocortisone in the management of hyponatremia after aneurysmal subarachnoid hemorrhage.


  • The post-resuscitation VASOGRADE: a more accurate scale to predict delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage

    by Thomas Ritzenthaler, Thomas Ritzenthaler, Thomas Ritzenthaler, Florent Gobert, Florent Gobert, Florent Gobert, Baptiste Balança, Baptiste Balança, Baptiste Balança, Frederic Dailler, et al.

    Background Predicting the occurrence of delayed cerebral ischemia (DCI) after aneurysmal subarachnoid hemorrhage is of interest to adjust the level of care. The VASOGRADE, a simple grading scale using admission World Federation of Neurosurgical Societies (WFNS) grading score and modified Fisher scale (mFS) on first CT scan, could help to select patients at risk of DCI. However, using data after initial resuscitation (initial complication treatment, aneurysm exclusion) may be more relevant. Methods We calculated a post-resuscitation VASOGRADE (prVG) using WFNS grade and mFS after early brain injury treatment and aneurysm exclusion (or at day 3). Patients were categorized as green, yellow, or red. Results Using our prospective observational registry, 566 patients were included in the study. Two hundred six (36.4%) were classified as green, 208 (36.7%) as yellow, and 152 (26.9%) as red, and DCI was experienced in 22 (10.7%), 67 (32.2%), and 45 (29.6%) cases respectively. Patients classified as yellow had higher risk of developing DCI (OR 3.94, 95% CI 2.35–6.83). Risk was slightly lower in red patients (OR 3.49, 95% CI 2.00–6.24). The AUC for prediction was higher with prVG (0.62, 95% CI 0.58–0.67) than with VASOGRADE (0.56, 95% CI 0.51–0.60) (p < 0.01). Conclusion By using simple clinical and radiological scale evaluated at subacute stage, prVG is more accurate to predict the occurrence of DCI.


  • Nicotine Replacement Therapy Does Not Reduce Headaches Following Subarachnoid Hemorrhage: A Propensity Score-Matched Study

    by Aude Charvet, Baptiste Bouchier, Frédéric Dailler, Thomas Ritzenthaler

    Background A significant number of patients admitted for aneurysmal subarachnoid hemorrhage (aSAH) are active smokers and are at risk of developing nicotine withdrawal symptoms (e.g., cravings, irritability, insomnia, headaches, etc.). This study aimed to evaluate the use of nicotine replacement therapy (NRT) regarding headache severity and analgesics consumption. Methods A retrospective study was conducted using prospectively collected data from 2014 to 2019 in the neurointensive care unit of the Hospices Civils in Lyon, France. We performed a propensity score matching analysis. The covariables used were age, sex, initial World Federation of Neurosurgical Societies score, Hijdra sum score, and factors associated with pain following aSAH (history of chronic pain, anxiety, or depression). Smokers received NRT through a transdermal device. The primary end point was headache control. Secondary end points were mean numerical pain rating scale score and analgesics consumption. Results One hundred and fifty-five patients were included among 523 patients hospitalized for aSAH. Fifty-one patients underwent nicotine substitution and were matched to 51 unsubstituted patients. The headache control rate was not different between the two groups (43.1% vs. 31.4%, p = 0.736). The mean numeric pain rating scale score in the substituted group was 2.2 (1.1–3.5) and 2.4 (1.6–3.1) in the unsubstituted group (p = 0.533). The analgesics consumption (acetaminophen, tramadol, and morphine) was the same in the two groups. Conclusions The use of NRT in the acute phase of aSAH does not seem to have an impact on the intensity of headaches or analgesics consumption.

  • Open Access

    Significance and Diagnostic Accuracy of Early S100B Serum Concentration after Aneurysmal Subarachnoid Hemorrhage

    by Baptiste Balança, Thomas Ritzenthaler, Florent Gobert, Caroline Richet, Carole Bodonian, Romain Carrillon, Anne Terrier, Laurent Desmurs, Armand Perret-Liaudet, Frédéric Dailler

    Background: Early brain injuries (EBI) are one of the most important causes of morbidity and mortality after subarachnoid hemorrhage. At admission, a third of patients are unconscious (spontaneously or sedated) and EBI consequences are not evaluable. To date, it is unclear who will still be comatose (with severe EBI) and who will recover (with less severe EBI) once the aneurysm is treated and sedation withdrawn. The objective of the present study was to determine the diagnostic accuracy of S100B levels at hospital admission to identify patients with severe neurological consequences of EBI. Methods: Patients were consecutively included in this prospective blinded observational study. A motor component of the Glasgow coma score under 6 on day 3 was used to define patients with severe neurological consequences of EBI. Results: A total of 81 patients were included: 25 patients were unconscious at admission, 68 were treated by coiling. On day 3, 12 patients had severe consequences of EBI. A maximal S100B value between admission and day 1 had an area under the receiver operating characteristic curve (AUC) of 86.7% to predict severe EBI consequences. In patients with impaired consciousness at admission, the AUC was 88.2%. Conclusion: Early S100B seems to have a good diagnostic value to predict severe EBI. Before claiming the usefulness of S100B as a surrogate marker of EBI severity to start earlier multimodal monitoring, these results must be confirmed in an independent validation cohort.


  • Do not rely on imaging to predict awakening: The value of neurophysiology in a case of Weston-Hurst syndrome

    by Florent Gobert, Thomas Ritzenthaler, Nathalie André-Obadia, Fréderic Dailler


  • “Vasospasm Mimic” After Aneurysmal Subarachnoid Hemorrhage

    by Thomas Ritzenthaler, Florent Gobert, Fréderic Dailler


  • Influence of vascular access devices upon efficiency of therapeutic plasma exchange

    by Thomas Ritzenthaler, Mickael Beraud, Florent Gobert, Frédéric Dailler

    Background: An efficient vascular access is mandatory for the proper conduction of therapeutic plasma exchanges (TPE). Peripheral and central venous catheters may be used, with respective advantages and limitations. In this study, vascular access devices (IV catheter, dialysis cannula, central venous catheter) and anatomic vein characteristics were evaluated.Method: From January to June 2016, 162 TPE in 29 patients were reviewed. Only TPE using centrifugation method (Spectra Optia apheresis system) were evaluated. Volume exchanged, procedure duration, mean flow rate, number of inlet, and return pressure pauses were recorded. Site, width, and depth of punctured veins were studied.Results: Median exchange volume planned was 3500 mL, and 152 (94%) procedures could be completed. Peripheral venous catheter was inserted in 103 (64%) cases (IV catheter: 61, dialysis cannulae: 42). Ultrasound guidance was used in 12 (11%) cases. Median procedure duration was shorter with central venous catheter (94 minutes), rather than dialysis cannula (133 minutes) or IV catheter (133 minutes). Median numbers of inlet pressure pauses were lower with central venous catheter (0) and dialysis cannulae (6), rather than IV catheter (10). There were no complications with peripheral venous access. There were no anatomic differences between catheterized veins with IV catheter or dialysis cannula.Conclusion: The use of peripheral venous access is possible in most of TPE, for emergency and during maintenance therapy. Dialysis cannulae are good compromise between classic IV catheters and central venous catheters, as it allows high flow rates, are easy to insert and associated with few complications.